Henrik B. Mortensen
Member of:
Paediatrics
Primary fields of research
Research areas: Pathophysiology and pathogenesis of type 1 diabetes with special attention to the remission phase in new onset type 1 diabetes. Identification of new biomarkers for beta cell replication or decay. Launch of intervention studies with the aim of preserving the residual beta cell function to prolong the remission phase or even make it permanent.
Total publications in peer-reviewed journals: 139, according to Science Citation Index, May 2013 with a total of 2071 citations, average citations per item 14.90, H-index 26. The highest number of publications in the years 2008- 2012 is achieved in 2010 with 10 papers. Patents: Mortensen HB, Hansen L.: Use of GLP-1 analogues in the treatment of type 1 diabetes. Patent application 6645.000-DK (2003).
Supervisor for 8 postgraduate students who have achieved the PhD degree. At present supervisor for 3 postgraduate students.
ID: 10416
Most downloads
-
148
downloads
No Contribution of GAD-65 and IA-2 Autoantibodies around Time of Diagnosis to the Increasing Incidence of Juvenile Type 1 Diabetes: A 9-Year Nationwide Danish Study
Research output: Contribution to journal › Journal article › peer-review
Published -
137
downloads
Genetic Risk Score Modelling for Disease Progression in New-Onset Type 1 Diabetes Patients: Increased Genetic Load of Islet-Expressed and Cytokine-Regulated Candidate Genes Predicts Poorer Glycemic Control
Research output: Contribution to journal › Journal article › peer-review
Published -
113
downloads
High neonatal blood iron content is associated with the risk of childhood type 1 diabetes mellitus
Research output: Contribution to journal › Journal article › peer-review
Published